RxDoctor Payments Data

Katherine Prince

Nurse Practitioner · Durham, NCNPI 1871967919

Payments from drug & device makers

$7,505in general payments, 2019–2025

Across 39 payments — averaging $192.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$6K
  • Blueprint Medicines Corporation$705
  • Sanofi$291
  • AstraZeneca$250
  • Regeneron Healthcare Solutions, Inc.$240
  • Pfizer$41

What the payments were for

  • Consulting fees$4,30057%
  • Speaking & faculty fees$6328%
  • Travel & lodging$6709%
  • Food & beverage$1,87725%
  • Education$260%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,505 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$16,179
Medicare patients
67
Services billed
352

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
HizentraImmun Glob G(Igg)/Pro/Iga 0-5095$632,342
CuvitruImmun Glob G(Igg)/Gly/Iga Ov5080$571,425
CutaquigImmun Glob G(Igg)-Hipp/Maltose25$206,883
Gamunex-CImmune Globul G/Gly/Iga Avg 4612$53,142
GammakedImmune Globul G/Gly/Iga Avg 4613$49,298
Qvar RedihalerBeclomethasone Dipropionate51$16,834
Breo ElliptaFluticasone/Vilanterol16$15,382
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$13,619
Epinephrine39$9,727
Advair HfaFluticasone Propion/Salmeterol17$7,785
Cromolyn Sodium16$7,149
SymbicortBudesonide/Formoterol Fumarate12$6,631
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate16$4,168
Montelukast Sodium96$1,112
Cefdinir25$680

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
CSL BehringHizentra$5,977$632,34295 claims
AstraZenecaSymbicort$250$6,63112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →